WC 800 (Mesalamine delayed-release 800 mg)
Pill imprint WC 800 has been identified as Mesalamine delayed-release 800 mg.
Mesalamine is used in the treatment of ulcerative colitis; crohn's disease; ulcerative colitis, active; crohn's disease, maintenance; inflammatory bowel disease (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 800 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WC 800
- Strength:
- 800 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- 5-aminosalicylates
- Pregnancy Category:
- B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD - CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Zydus Pharmaceuticals (USA) Inc.
More about mesalamine
Consumer resources
- Mesalamine controlled-release capsules
- Mesalamine delayed-release capsules
- Mesalamine delayed-release tablets
- Mesalamine enema
- Mesalamine extended-release capsules
- More (5) »
- Other brands: Asacol, Lialda, Pentasa, Apriso, More (7) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
